4//SEC Filing
Bergstein Ivan 4
Accession 0001104659-20-048399
CIK 0001264587other
Filed
Apr 19, 8:00 PM ET
Accepted
Apr 20, 6:07 AM ET
Size
5.9 KB
Accession
0001104659-20-048399
Insider Transaction Report
Form 4
Bergstein Ivan
DirectorCEO, Pres., Treas., Sec.10% Owner
Transactions
- Sale
Common Stock
2020-04-15$4.88/sh−53,618$261,656→ 2,804,336 total
Footnotes (3)
- [F1]In connection with the vesting of 94,916 shares on April 14, 2020, a total of 53,618 shares were sold by the Company on April 15, 2020 in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies.
- [F2]Reflects the weighted average sale price. The range of prices for the shares sold on April 15, 2020 was $4.79 to $5.06. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies.
- [F3]Of the shares listed, 762,035 shares are restricted stock.
Documents
Issuer
STEMLINE THERAPEUTICS INC
CIK 0001264587
Entity typeother
Related Parties
1- filerCIK 0001554767
Filing Metadata
- Form type
- 4
- Filed
- Apr 19, 8:00 PM ET
- Accepted
- Apr 20, 6:07 AM ET
- Size
- 5.9 KB